dapsone has been researched along with Abnormalities, Drug-Induced in 4 studies
Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Mild degrees of haemolysis consistently occur with continued therapy, although adverse effects may be less likely with intermittent treatment, as most reported adverse effects have occurred with long-term use of dapsone." | 6.42 | Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes. ( Brabin, BJ; Eggelte, TA; Parise, M; Verhoeff, F, 2004) |
| " Mild degrees of haemolysis consistently occur with continued therapy, although adverse effects may be less likely with intermittent treatment, as most reported adverse effects have occurred with long-term use of dapsone." | 2.42 | Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes. ( Brabin, BJ; Eggelte, TA; Parise, M; Verhoeff, F, 2004) |
| " The no or low adverse effect levels were in the range of 5 to 7 mg/kg/day artesunate." | 1.32 | Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit. ( A Clode, S; Clark, RL; Gaunt, I; Ward, SA; White, TE; Winstanley, P, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brabin, BJ | 1 |
| Eggelte, TA | 1 |
| Parise, M | 1 |
| Verhoeff, F | 1 |
| Clark, RL | 1 |
| White, TE | 1 |
| A Clode, S | 1 |
| Gaunt, I | 1 |
| Winstanley, P | 1 |
| Ward, SA | 1 |
| Littler, TR | 1 |
| Bhargava, P | 1 |
| Kuldeep, CM | 1 |
| Mathur, NK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity[NCT05757167] | Phase 4 | 2,500 participants (Anticipated) | Interventional | 2023-11-06 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for dapsone and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes.
Topics: Abnormalities, Drug-Induced; Animals; Antimalarials; Dapsone; Drug Resistance; Female; Humans; Infan | 2004 |
Anti-rheumatic drugs.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimalarials; Dapso | 1981 |
2 other studies available for dapsone and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit.
Topics: Abnormalities, Drug-Induced; Animals; Antimalarials; Artemisinins; Artesunate; Dapsone; Drug Combina | 2004 |
Antileprosy drugs, pregnancy and fetal outcome.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Animals; Clofazimine; Dapsone; Drug Therapy, Combina | 1996 |